Fate Therapeutics Inc (NASDAQ:FATE)
| 23.58 Delayed Data As of May 27 |  +1.15 / +5.13%Today’s Change | 20.49 Today|||52-Week Range 97.43 | -59.70% Year-to-Date |
Latest FATE News | Press Releases
| Analysts Tab Veeva Systems as a Top Value Pick May 25 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 22.43 |
| Today’s open | 22.68 |
| Day’s range | 21.74 - 23.70 |
| Volume | 97,801 |
| Average volume (3 months) | 1,406,284 |
| Market cap | $2.3B |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -6.39% |
| Earnings growth (this year) | -46.23% |
| Earnings growth (next 5 years) | -36.60% |
| Revenue growth (last year) | +77.66% |
| P/E ratio | NM |
| Price/Sales | 99.27 |
| Price/Book | 3.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARVNArvinas Inc | +1.87 | +4.53% |
| ---- | ||
| TLRYTilray Brands Inc | -0.12 | -2.58% |
| TWSTTwist Bioscience Cor... | +1.17 | +3.37% |
Data as of 4:00pm ET, 05/27/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.83 |
| Annual revenue (last year) | $55.8M |
| Annual profit (last year) | -$212.2M |
| Net profit margin | -379.89% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
